Abstract Details

Title Optical Coherence Tomography as a Clinical Trial Outcome Measure: Implications of Treating On-Study Relapses with Intravenous Methylprednisolone

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 065

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Norma Deri, MD (Merck Serono Argentina)	Norma Deri, MD has nothing to disclose.
	No disclosure on file
Jeffrey M. Katz, MD (North Shore University Hospital)	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��